Also known as Renagel and Renvela
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. It is marketed by Genzyme (now Sanofi-Aventis) under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).Source: Wikipedia
Estimated Total Cost: $453.29 for an average of 28 days supply
Patients are most commonly prescribed sevelamer to treat kidney failure, kidney disease due to longstanding hypertension, chronic ulcer, and chronic kidney disease.